⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Filed Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
MLTX SECURITIES REMINDER: Lose Money on MoonLake Immunotherapeutics? You Have Rights And Are Notified to Contact BFA Law Before December 15 Deadline
accessnewswire.com
MLTX
Class Action Lawsuit Filed: MoonLake Immunotherapeutics (MLTX) - Join by December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky Before December 15, 2025 to Join Class Action
accessnewswire.com
MLTX
SueWallSt Podcast Series Launches With Focus on MoonLake Immunotherapeutics (MLTX) Fraud Allegations
accessnewswire.com
MLTX
Class Action Lawsuit Filed: MoonLake Immunotherapeutics (MLTX) - Join by December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX